Finally, RO-EA NTS loaded in situ gel may provide a novel strategy (using the deformable vesicular system as carriers) to improve bioavailability, enhance caspase-3-mediated apoptosis, and increase the levels of P21 protein (tumor suppressor protein) in treating tongue carcinomas. The gene discussed is CASP3; the disease is tongue cancer.